Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash from Financing Activities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Cash from Financing Activities for 5 consecutive years, with $42.4 million as the latest value for Q4 2020.

  • Quarterly Cash from Financing Activities changed N/A to $42.4 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $66.7 million through Dec 2020, up 1272.88% year-over-year, with the annual reading at $69.4 million for FY2025, 33.75% up from the prior year.
  • Cash from Financing Activities for Q4 2020 was $42.4 million at Forte Biosciences, up from $166000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $87.2 million in Q2 2017, with the low at -$1.8 million in Q3 2017.
  • Average Cash from Financing Activities over 5 years is $12.8 million, with a median of $968000.0 recorded in 2019.
  • The sharpest move saw Cash from Financing Activities skyrocketed 379052.17% in 2017, then crashed 133.79% in 2018.
  • Over 5 years, Cash from Financing Activities stood at -$23000.0 in 2016, then tumbled by 5726.09% to -$1.3 million in 2017, then skyrocketed by 2228.21% to $28.5 million in 2018, then plummeted by 89.18% to $3.1 million in 2019, then surged by 1273.72% to $42.4 million in 2020.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $42.4 million, $166000.0, and $24.1 million for Q4 2020, Q3 2020, and Q2 2020 respectively.